FDA
approval
· 2021-02-02
FDA Approved: BUPRENORPHINE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
Summary
The FDA approved a supplemental application for buprenorphine submitted by Amneal Pharmaceuticals NY LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)